Skip to content
ppharmaranks
Menu
Class IIOngoing

Midodrine Hydrochloride Tablets recall

FDA recall D-0383-2026 · initiated Feb 17, 2026

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 11, 2026How we research

The Harvard Drug Group LLC recalled Midodrine Hydrochloride Tablets in Feb 2026 — an FDA Class II recall (D-0383-2026) because Defective container; inadequately sealed blister packaging.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Defective container; inadequately sealed blister packaging.

Labelling, packaging or a product mix-up

The wrong information — or the wrong medicine — ended up in the pack. A mix-up is a manufacturing failure that can still be dangerous to swallow.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot # N02640, Exp Date: 08/2027

Quantity recalled: 8892 cartons

Details

Product
Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
Recalling company
The Harvard Drug Group LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide US.
Initiated
Feb 17, 2026
FDA report date
Mar 11, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Midodrine Hydrochloride Tablets recalled?
The Harvard Drug Group LLC recalled Midodrine Hydrochloride Tablets in Feb 2026 — an FDA Class II recall (D-0383-2026) because Defective container; inadequately sealed blister packaging. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Midodrine Hydrochloride Tablets recalled?
Per the FDA enforcement record, the reason for recall D-0383-2026 was: Defective container; inadequately sealed blister packaging.
Is a recalled Midodrine Hydrochloride Tablets dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Midodrine Hydrochloride Tablets are affected?
Distributed: Nationwide US.. The recall covers these lots — Lot # N02640, Exp Date: 08/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0383-2026.

Source: openFDA Drug Enforcement record D-0383-2026

← All drug recalls